The 14th edition of BioAsia 2017 is scheduled to be held in Hyderabad at Hyderabad International Convention Center (HICC) from February 6.
This time BioAsia 2017, is expected to bring together on its platform some of the top influential executives from global pharma and biotechnology powerhouses such as Dr. Paul Stoffels, Worldwide Chairman of Pharmaceuticals and Chief Scientific Officer from Johnson & Johnson, Vasant Narasimhan, Global Head of Drug Development and Chief Medical Officer from Novartis, Dr. Patrick Vallance, President Worldwide Pharmaceuticals, R&D from GSK, among many others.
In fact during the past more than a decade now, BioAsia, has been the leading flagship annual event of the state government. Organized by the Department of Industries and Commerce, Government of Telangana, this event has emerged as a preeminent technology and bio-business convention in Asia for Life sciences, pharmaceuticals and healthcare.
This year, the organizers of BioAsia are expecting participation of 1,500 delegates from across 50 countries. “We are expecting a huge number of delegates from 800 Corporates across the globe. About one 100 high profile speakers will give presentations and deliberate on various topics of biotechnology, pharmaceuticals and healthcare during the 3 day event,” informed Shakthi Nagappan, CEO of BioAsia.
As Hyderabad is already the life sciences hub of India, the department of industries and commerce lead by Minister K T Ramarao, government of Telangana is making every effort to make this event a historic one. “We are fortunate to host BioAsia in Hyderabad and we are expecting that this event will add momentum to some of the landmark initiatives taken up by the state government such as Hyderabad Pharma City, Genome Valley and Medical Devices Park,” said K T Ramarao.
Narayana Murthy, Founder of Infosys, Prof. Kurt Wuthrich, Nobel Laureate in Chemistry, Scripps Research Institute, USA, Dr. Satish Reddy, Chairman of Dr. Reddy’s Laboratories, Dr. Shailesh Ayyangar, Managing Director India and VP South Asia of Sanofi, BVR Mohan Reddy, Founder & Executive Chairman of CYIENT and Former Chairman of NASSCOM, Zenia Tata, Executive Director of Global Development & International Expansion, XPRIZE from USA, Dr. Murtaza Khorakiwala, Managing Director of Wockardt, S Sridhar, Managing Director of Pfizer India, Sanjiv Navangul, Managing Director of Janssen India, KG Ananthakrishnan, Managing Director of MSD India, Srini Srinivasan, Managing Director of Hospira India, are some of the leading industry leaders who are expected to take part in the upcoming BioAsia in Hyderabad.